2Wei-Tien Tai,Ann-Lii Cheng,Chung-Wai Shiau,Hsiang-Po Huang,Jui-Wen Huang,Pei-Jer Chen,Kuen-Feng Chen.Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma[J].Journal of Hepatology.2011(5)
3George R. Blumenschein,Gordon B. Mills,Ana M. Gonzalez-Angulo.Targeting the Hepatocyte Growth Factor–cMET Axis in Cancer Therapy[J].Journal of Clinical Oncology.2012(26)
4Yoon-Koo Kang,Kei Muro,Min-Hee Ryu,Hirofumi Yasui,Tomohiro Nishina,Baek-Yeol Ryoo,Yukimasa Kamiya,Shiro Akinaga,Narikazu Boku.A phase II trial of a selective c-Met inhibitor tivantinib (ARQ 197) monotherapy as a second- or third-line therapy in the patients with metastatic gastric cancer[J].Investigational New Drugs.2014(2)
5Andrew S Giraud,Trevelyan R Menheniott,Louise M Judd.Targeting STAT3 in gastric cancer[J].Expert Opinion on Therapeutic Targets.2012(9)
6Brendan D. Manning,Lewis C. Cantley.AKT/PKB Signaling: Navigating Downstream[J].Cell.2007(7)
7Timothy Iveson,Ross C Donehower,Irina Davidenko,Sergey Tjulandin,Andrzej Deptala,Mark Harrison,Somanath Nirni,Kuntegowdanahalli Lakshmaiah,Anne Thomas,Yizhou Jiang,Min Zhu,Rui Tang,Abraham Anderson,Sarita Dubey,Kelly S Oliner,Elwyn Loh.Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study[J]. Lancet Oncology . 2014 (9)
8Min Li,Huawen Sun,Lujun Song,Xiaodong Gao,Wenju Chang,Xinyu Qin.Immunohistochemical expression of mTOR negatively correlates with PTENexpression in gastric carcinoma[J]. Oncology Letters . 2012 (6)
9Bin Zhang,Yan Yang,Xiaoting Shi,Wanyu Liao,Min Chen,Alfred Sze-Lok Cheng,Hongli Yan,Cheng Fang,Shu Zhang,Guifang Xu,Shanshan Shen,Shuling Huang,Guangxia Chen,Ying Lv,Tingsheng Ling,Xiaoqi Zhang,Lei Wang,Yuzheng Zhuge,Xiaoping Zou.Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial–mesenchymal transition[J]. Cancer Letters . 2014
10Li Vivian Sze Wing,Wong Chi Wai,Chan Tsun Leung,Chan Agnes Sze Wah,Zhao Wei,Chu Kent-Man,So Samuel,Chen Xin,Yuen Siu Tsan,Leung Suet Yi.Mutations of PIK3CA in gastric adenocarcinoma. BMC Cancer . 2005
